We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
This consultation contains proposals to amend the Home Office’s policy for the licensing of imports of the opioid oxycodone in the UK.
The government is helping people make a full recovery from drug addiction and is discouraging people from misusing illegal drugs in the first place.
First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government
This consultation sought comments on proposals to consolidate and review specific provisions under the Misuse of Drugs Regulations 2001
Report by the Advisory Council on the Misuse of Drugs (ACMD) reviewing the use of cocaine powder and its impact on British society.
The (ACMD) Recovery Committee’s briefing paper on the prevention of drug and alcohol dependence.
'Ketamine: rescheduling and patient group directions' provides further advice from the Advisory Council on the Misuse of Drugs (ACMD) to the Home Secretary.
Advisory Council on the Misuse of Drugs’ report on the synthetic stimulant known as 4,4’-DMAR.
Advisory Council on the Misuse of Drugs’ report on the synthetic opioid known as MT-45.
Report to Lynne Featherstone in response to Norman Baker's request for advice on whether opioid substitution therapy should be time limited.
Home Office evidence review (2014) on new psychoactive substances in England, which informed the new psychoactive substances review by an expert panel.
Government's response to the recommendations and advice made by the expert panel reviewing the UK’s response to new psychoactive substances.
Report on the 2013 to 2014 international comparators study of approaches to drug-related issues by the UK and other countries. This is a supporting document to the 2010 drug strategy.
Report looks into the effectiveness and issues of the UK’s current legislative and operational response to NPS and the ongoing challenges.
Advisory Council on the Misuse of Drugs publishes recommendations and report on the new psychoactive substance tryptamines.
Advisory Council on the Misuse of Drugs publishes recommendations and report on the new psychoactive substance and synthetic opiate AH-7921.
Consultation on new powers to allow law enforcement agencies to seize chemical substances suspected of being used as drug cutting agents
Consultation on the scheduling of tramadol and a review of exemptions for temazepam prescriptions under Misuse of Drugs Regulations 2001.
Review of the evidence of misuse and harm in relation to the NBOMe compounds.
The second annual review of the drug strategy, 'Delivering within a new landscape', updates progress on the 3 strands of the strategy since May 2012.
'Ketamine: a review of use and harm' provides advice from the Advisory Council on the Misuse of Drugs to the Home Secretary.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).